Anxiety Sensitivity Treatment for Heroin Users (ASTH-HR)

University of Maryland

Status: Completed

Conditions: Anxiety

Treatments: Behavioral: Anxiety sensitivity therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01196312

DA023384

Details and patient eligibility

About

Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• exhibit a score of 21 on a self-report measure of anxiety sensitivity
• be in 28 days of residential substance use treatment.
• meet criteria for current opioid dependence as determined by SCID interview administered at intake.

Exclusion criteria

• evidence of limited mental competency
• the inability to give informed, voluntary, written consent to participate
• current psychosis
• current bipolar disorder.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)